ScholarIQanswers from OpenAlex

Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease

PaperCitations, authors & open-access status

Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease have?

ScholarIQcitation count

Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease has 11 citations in the OpenAlex counts ScholarIQ stores.

When was Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease published?

ScholarIQyear

Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease has 2025 year in the ScholarIQ index.

What is the open-access status of Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease?

ScholarIQoa status

Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease has gold oa status in the ScholarIQ index.

What is the DOI of Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease?

ScholarIQdoi

The DOI for Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease is on the source record.

What is the PMID of Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease?

ScholarIQpmid

The PMID for Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease is on the source record.

What is the OpenAlex record for Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease?

ScholarIQopenalex

The OpenAlex for Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial